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PURPOSE. To investigate the impact of obstructive sleep apnea (OSA) on the contribution of
inner and outer retinal photoreceptors to the pupillary light response (PLR).
METHODS. Ninety-three eyes from 27 patients with OSA and 25 healthy controls were tested.
OSA severity was graded according to the apnea-hypopnea index. PLR was measured
monocularly with an eye tracker in a Ganzfeld in response to 1-second blue (470 nm) and red
(640 nm) flashes at 3, 2, 1, 0, 1, 2, and 2.4 log cd/m2. Peak pupil constriction amplitude,
peak latency, and the postillumination pupil response were measured. The Cambridge Colour
Test, standard automatic perimetry, spectral domain optical coherence tomography,
polysomnography, and the Pittsburgh Sleep Quality Index were used.
RESULTS. OSA patients have a significantly decreased peak pupil constriction amplitude for
blue stimuli at 3, 2, 1, 1 log cd/m2 and at all red flash luminances (P < 0.050), revealing
reduction of outer retina contributions to PLR. OSA patients showed reduced peak latency for
blue (2, 0, 2, 2.4 log cd/m2) and red stimuli (2, 0 log cd/m2; P < 0.040). No significant
difference was found in the melanopsin-mediated PLR.
CONCLUSIONS. This study is the first to evaluate the inner and outer retinal contributions to PLR
in OSA patients. The results showed that the outer retinal photoreceptor contributions to PLR
were affected in moderate and severe OSA patients. In contrast, the inner retina contributions
to PLR are preserved.
Keywords: obstructive sleep apnea, pupillary light responses, classical photoreceptors,
intrinsically photosensitive retinal ganglion cells, circadian rhythm, retinal nerve fiber layer
thickness, visual field defect
Obstructive sleep apnea (OSA) is a highly prevalent chronicsleep disorder. According to some epidemiologic studies,
prevalence of moderate-to-severe OSA varies from 6% to 17% in
the general adult population1,2 and reaches a maximum
between the fifth and seventh decades.2 OSA involves repeated
episodes of partial or complete obstruction of the upper airway
during sleep,3 associated with a decreased oxyhemoglobin
saturation and a consequent arterial hypoxemia and hypercap-
nia, repetitive arousals, intrathoracic pressure changes, hypox-
ia, endothelial dysfunction, oxidative stress, and activation of
systemic inflammation.4–7 OSA patients present an autonomic
nervous system (ANS) imbalance due to sleep fragmentation,
which involves recurrent arousals that can precipitate post-
apneic surges in blood pressure and heart rate, which may
occur even during wakefulness.8,9 These pathophysiological
changes have been associated with increased risk for several
systemic and neurodegenerative diseases involving cardiovas-
cular, metabolic, neurologic,5,10 Parkinson11 and Alzheimer
disease,12 as well as with some ophthalmic disorders, such
glaucoma,13 floppy eyelid syndrome,14,15 nonarteritic ischemic
optic neuropathy,16 and retinal vein occlusion.17
The visual system requires large amounts of metabolic
energy and the photoreceptor cells demand high oxygen
consumption.18 The retina is particularly susceptible to
oxidative stress. As a consequence, the deoxygenation and re-
oxygenation phenomena associated with apnea may contribute
to endothelial injury and compromise the optic nerve integrity
and its function.7,19 In fact, many studies have reported a strong
link between OSA and optic nerve disorders, associated with a
decrease of nerve fiber layer (RNFL) thickness.7,19–21 This
thinning of the RNFL in OSA may lead to a dysfunction of the
retinal ganglion cells (RGC). In fact, a disrupted circadian
rhythm and abnormal melatonin secretion pattern in OSA
patients have been reported,22–24 and it is known that the RGC
subpopulation of intrinsically photosensitive ganglion cells
(ipRGCs) is involved in circadian photoentrainment and in the
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regulation of melatonin secretion. These RGCs, also known as
the third class of photoreceptor,25,26 contain the melanopsin
photopigment and are known to mediate nonimage-forming
visual functions, which include a wide range of responses to
light—circadian photoentrainment, sleep regulation, pupillary
light response (PLR), and modulation of mood and learn-
ing.27–31 The possible effects of OSA upon the ipRGCs has not
been investigated so far.
The PLR can be used as a noninvasive tool and as an
alternative to electroretinography to evaluate retinal and optic
nerve functions.32–40 It is possible to assess the contribution of
outer (rod and cone) and inner (ipRGC) retinal photoreceptors
by the characteristics of the response to light stimuli of
appropriate wavelengths and intensities for each photosensi-
tive cell group.27,33,41–45 The outer retinal contributions to the
PLR are responsible for the transient constriction, while the
inner retinal contribution mediates the sustained constriction
during the return to the baseline pupil amplitude.27–31
Therefore, the goal of this study was to evaluate the
contribution of inner and outer retinal photoreceptors to the
PLR in patients with moderate and severe OSA and to correlate
these findings with parameters of visual function (visual field
perimetry, color vision), retinal morphology (optical coher-
ence tomography [OCT]) and polysomnography [PSG]).
METHODS
Study Design
This cross-sectional study was designed to investigate the
contributions of the inner and outer retina to the PLR in OSA
patients. This study was approved by the Brazilian National
System for Ethics in Research – SISNEP, Brazil (CAAE:
15172113.0.0000.5561) and conducted in strict adherence to
the tenets of the Declaration of Helsinki. Informed written
consent was obtained from all study participants.
Subjects
Ninety-three eyes from 27 patients with OSA aging from 37 to
73 years (mean ¼ 54.28 6 8.89 years, 13 females) and 25
healthy control participants aging from 38 to 74 years (mean¼
52.60 6 9.13 years, 17 females) were recruited from
Department of Otolaryngology of Medical School of the
University of Sao Paulo in Brazil. Participants were all those
who met the inclusion criteria and did not fit in the exclusion
criteria described below. All subjects underwent a complete
ophthalmologic evaluation, including a medical history review,
best-corrected visual acuity measurement, gonioscopy, slit-
lamp biomicroscopy, dilated funduscopic examination using a
78 diopter (D) lens, refraction, intraocular pressure (IOP)
measurement, visual field (VF) test mean deviation (MD) by
standard automated perimetry (SAP) using the Swedish
interactive threshold algorithm (SITA Standard 24–2; Carl Zeiss
Meditec, Inc., Dublin, CA, USA), and RNFL thickness evaluated
by spectral-domain OCT. All tests were performed within 4-
month intervals.
The inclusion criteria were age between 35 and 75 years,
best-corrected visual acuity equal to or better than 0.3 logMAR
in the study eye, spherical refraction within 6 5.00 D and
cylinder refraction within 6 3.00 D, transparent ocular media
(lens opacity <1) based on the Lens Opacities Classification
System III system,46 a normal VF (defined as a Glaucoma
Hemifield Test [GHT] within normal limits and a MD ‡ 2.0
dB), and an IOP less than 21 mm Hg. On the other hand, the
exclusion criteria were concomitant ocular disease, history of
ophthalmic surgery, neurologic or psychiatric illness, diabetes,
smoking or alcohol abuse history, use of topical or systemic
medication, which could potentially affect the pupillary
response.
Only patients diagnosed with moderate or severe OSA were
enrolled in the study. OSA severity was graded according to the
apnea-hypopnea index (AHI) calculated as the number of
events of desaturation and apnea or hypopnea (cessation or
decrease in respiratory airflow, respectively) per hour of sleep.
Subjects with an AHI of 15 or more and less than 30 were
regarded as having moderate OSA or severe OSA if the AHI 30
or more. AHI and the oxygen desaturation index (ODI), which
is the number of times per hour of sleep that the blood’s
oxygen level drops by a certain degree from baseline, were
used for correlation.
Polysomnography (PSG)
The diagnosis of OSA was based on results of a full night
assisted PSG diagnosis at the Sleep Laboratory of the
Department of Otolaryngology of the University Hospital
‘‘Hospital das Cl´ınicas’’ of Sao Paulo University. PSG assessment
was carried out using the polisomnograph Embla (Embla
s4000; Embla Systems, Inc., Broomfield, CO, USA) and data
were analyzed using Remlogic 1.3 software (Embla Systems,
Inc.). PSG data recording followed the American Academy of
Sleep Medicine recommendations4 and included electroen-
cephalogram (F4/M1, C4/M1, O2/M1), submental electromyo-
gram, t ib i a l i s an ter ior musc le e lec t romyogram,
electrooculogram (E1/M2, E2/M2), electrocardiogram, airflow
(nasal cannula and oronasal thermistor), respiratory effort with
thoracic and abdominal inductance plethysmographic belts,
pulse oximetry measurements, body position, and snoring
intensity. All the sleep tests were manually scored by a certified
sleep physician.
The Pittsburgh Sleep Quality Index
Subjective assessment of sleep quality was performed using the
Pittsburgh Sleep Quality Index (PSQI).47 Participants were
required to complete this questionnaire, which consists of
seven subscales with 19 questions that represent the total
sleep quality score ranging from 0 to 21, where higher scores
indicate worse sleep quality. Patients with a global score equal
to 5 or higher were considered poor sleepers.
Rod, Cone, and ipRGC Contributions to the PLR
Stimuli consisted of a 1-second blue (470 nm) and red (640
nm) light flashes, generated in a Ganzfeld (Q450; Roland
Consult, Brandenburg, Germany), controlled by the A-pattern
simulation system (RETI–port; Roland Consult). We use
photopic luminance values. The units are given as log cd/m2.
Flashes were presented at the following luminances: 3, 2,
1, 0, 1, 2, 2.4 log cd/m2. Photopic and melanopic weighted
‘‘alpha-opic’’ luminance calculated according to Lucas et al.48
are shown in Supplementary Table S1. The Ganzfeld was
factory calibrated; we verified this with a Konica Minolta CS-
100A luminance and color meter for the luminance levels (0, 1,
2, 2.4 log cd/m2). For the red and blue flashes, we used specific
light-emitting diodes (LEDs) of the Ganzfeld with peak
wavelengths at 470 (blue) and 640 nm (red) and full width at
half maximum of 26 and 17 nm, respectively. We chose
stimulus duration, wavelengths, and luminance based on
previous studies.33,35
To evaluate the activity of the ipRGCs, flashes at 470 nm
were used with luminance from 1 to 2.4 log phot cd/m2,
alternating with flashes at 640 nm (which falls away from the
peak of the melanopsin light absorption spectrum). We used
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flashes at 470 nm below 0 log cd/m2 to isolate mainly the rod
contributions to the PLR. The rods mediate the transient PLR
phase, particularly at low luminance.25,26,32,33,49,50 However,
rods have been recently revealed to respond at low and
medium intensity red stimuli,45 and it seems that they
contribute at very bright light intensities to circadian photo-
entrainment as well.50,51 It is also known that cones have a
contribution to the transient PLR phase, especially in response
to long wavelength stimuli (640 nm), and high lumi-
nance.43,44,52
Procedure
Measurements of the PLR were done with an infrared eye-
tracking camera system (View Point, Arrington Research,
Scottsdale, AZ, USA) at 60 Hz sample rate of real-time pupil
recording. Subjects were dark adapted for 10 minutes. Both
eyes were tested monocularly by covering one eye with an eye
patch, in a random order. After dark adaption, for each
luminance level a red flash was presented followed by a blue
flash after the offset recording of the red flash. All flashes were
1 second in duration. Responses to flashes below 0 log cd/m2
were separated by at least 30 seconds of dark adaptation. For
the photopic range of luminances 1, 2, 2.4 log cd/m2 we used
an interstimulus interval of 90 seconds of dark adaptation (Fig.
1). The protocol to evaluate the PLR was performed around
either 10:30 AM or 3 PM. To determine if daytime affected the
baseline or the ipRGC contributions to PLR53,54 a pilot study
involving 10 subjects was conducted and the statistical analysis
did not show significant differences for the baseline, peak
pupil constriction amplitude, and the sustained re-
sponse33,41,43 (also named the postillumination pupil response
[PIPR])52,55,56 at 0, 1, 2, and 2.4 log cd/m2 (P > 0.050). The
subjects were instructed to abstain from eating banana,
chocolate, or drinking coffee the day of the test.57–60
PLR Analysis
Pupillometric recordings were analyzed using the average
pupil diameter during 3 seconds before the flash onset as a
baseline value. Noise and blinking artifacts were removed from
recordings with median filtering using a 200-ms window and
derivative filtering. Responses irreparably contaminated (eye
blinks or slow drifts >200 ms) were excluded. The filtered
response values were divided by the baseline pupil diameter to
normalize the PLR parameters and compare the results among
different subjects. Normalized peak pupil constriction ampli-
tude was estimated as the maximum pupil constriction and
expressed relative to the baseline value. The peak latency (PL)
was defined as the time from stimulus onset to the peak pupil
constriction amplitude (PA). The PIPR was expressed as the
median pupil diameter between 6 and 8 seconds after the flash
offset, relative to the baseline. The percentage of rejected peak
pupil constriction amplitude responses at all luminance was
3.16% and for the PIPR it was 1.65%.
Cambridge Colour Test (CCT)
Measurements of the color discrimination thresholds were
done using the CCT v2.0 in its Tri-vector and Ellipses protocols
with stimuli generated by a ViSaGe 2/5 graphics card (Cam-
bridge Research Systems, Rochester, England, UK) and a
gamma corrected Sony FD Trinitron color monitor (Model
GDM-F500T9; Sony Corporation, Tokyo, Japan). The procedure
of calibration was performed using the OptiCAL 200-E
photometer and the standard calibration routine of the VSG
Desktop library (version 8.0) provided by Cambridge Research
Systems.
The design of the CCT is based on the same principle as the
Ishihara pseudoisochromatic plates. The adoption of spatial
noise and luminance noise in the stimuli is intended to
eliminate the influence of spatial contour or luminance clues in
the color discrimination response. In the CCT, a mosaic
composed of small circles of several sizes and luminance
constitutes both the target and the background. A subset of
these circles presented at a different chromaticity from the
background forms a Landolt ‘‘C’’ stimulus target. The diameter
of the circles varied from 5.7 to 22.8 arcmin and their
luminance ranged from 7 to 15 phot cd/m2. The background
chromaticity was set at u’ ¼ 0.1977 and v’ ¼ 0.4689, in CIE
1976 Color Space. Subjects were tested in a darkened room
and seated at 3 m from the monitor, the outer diameter of the
Landolt’s ‘‘C’’ subtended 4.48 visual angle, the inner diameter
2.38; and the gap subtended 0.88.
Monocular tests were performed in both eyes in a randomly
selected order. The target was randomly presented with the
gap at one of the following four positions: up, down, right, or
left (4-alternative forced choice). Subjects were instructed to
identify the position of the gap in the ‘‘C’’ using a remote
response box control (CT6, CRS). The CCT was performed in
its two testing procedures, the Trivector test used to measure
thresholds along three confusion axes, protan, deutan, and
tritan, and the Ellipses test used to estimate a MacAdam ellipse
interpolated along the thresholds obtained at each of eight
vectors.
Optical Coherence Tomography (OCT)
Analysis of the peripapillary RNFL thickness was performed
using a Cirrus HD-OCT (software v. 5.2, model 4000; Carl Zeiss
Meditec, Inc.), which uses a super-luminescent diode scan
with a center wavelength of 840 nm and an acquisition rate of
27000 A-scans per second at an axial resolution of 5 lm.
Peripapillary RNFL measurements were obtained using a
FIGURE 1. Stimulus protocol for PLR. After 10 minutes of dark adaption for each luminance level a red flash (red rectangles) was presented
followed by a blue flash (blue rectangles) after terminating the recording of the red flash. All flashes were 1 second in duration. Pupil size was
recorded during 1 minute. Responses to flashes below 0 log phot cd/m2 were separated by at least 30 seconds of dark adaptation. For the photopic
range of luminances, 1, 2, 2.4 log photopic cd/m2 we used an interstimulus interval of 90 seconds of dark adaptation.
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circular sweep with a fixed diameter of 3.45 mm around the
optic disc. All information was reviewed and confirmed for the
absence of movement artifacts, good centering on the optic
disc, and a signal strength above 7. Scans were also evaluated
in terms of the adequacy of the algorithm for detecting the
RNFL. Only scans without overt algorithm failure in detecting
the retinal borders were included.
Data Analysis
The Shapiro-Wilk test was performed to assess the normal
distribution and graphic inspection of the data. Data from both
eyes for each participant were collected to increase potentially
the power of the study. In order to compare data across
groups, we used a general estimating equations (GEE) method
to adjust within subject intereye correlations.61,62 Further-
more, single-eye analyses were made using the Mann-Whitney
U test, left eyes were chosen for this specific analysis (see
Supplementary Table S2). For variables with parametric
distributions, a t-test was performed and for variables with
nonparametric distributions, Mann-Whitney U test was used.
To analyze sex and age differences between groups, v2 test was
conducted for sex, and an ANOVA for age. ANOVA was
performed with Brown Forsythe correction. Pearson and
Spearman correlation coefficients were used to measure the
degree of association between some variables that showed
losses in the OSA group. For the linear regression analysis, we
used only the variables that had a moderate or strong
correlation. Whenever both eyes were eligible, the right eye
was arbitrarily chosen for this specific analysis.
For all statistical tests, the level of significance was set at a¼
0.05. We used SPSS (version 24.0, SPSS Statistics; IBM, Corp,
Armonk, NY, USA) and Stata (version 12.0, StataCorp, College
Station, TX, USA) as the software for conducting analyses.
The datasets supporting the conclusions of this manuscript
are available on open science framework: https://osf.io/
7qwhn.
TABLE 1. Demographic, Clinical, and Polysomnographic Data of all Participants
Control Group OSA Group, Moderate to Severe OSA
P Valuen Mean 6 SD Eyes 95% CI n Mean 6 SD Eyes 95% CI
Sex
Female 17 (68%) – 31 – 13 (48.1%) – 24 – –
Male 8 (32%) – 15 – 14 (51.9%) – 23 – –
Total 25 46 27 47 0.109*
Age, y 54.28 6 8.89 50.61–57.95 52.60 6 9.13 48.98–56.21 0.505†
Ophthalmologic characteristics
BCVA, logMAR 0.05 6 0.07 0.03–0.07 0.18 6 0.61 0.04 to 0.40 0.506‡
SE, D 1.21 6 1.42 0.69–1.71 0.15 6 1.35 0.36 to 0.66 0.005‡
IOP, mm Hg 13.65 6 1.84 13.00–14.29 14.85 6 2.18 14.08–15.62 0.008‡
Cup-to-disc ratio 0.40 6 0.15 0.35–0.45 0.53 6 0.58 0.28–0.78 0.584‡
MD SAP, dB 1.08 6 2.02 1.79 to 3.76 1.08 6 1.47 1.60 to 5.59 0.997§
PSD SAP 2.86 6 1.92 2.19–3.53 2.34 6 1.00 1.99–2.69 0.581‡
VFI SAP 97.26 6 4.19 95.80–98.72 97.48 6 1.69 96.78–98.18 0.071‡
OCT RNFL thickness, lm 96.53 6 8.26 93.81–99.24 99.41 6 13.94 94.55–104.28 0.297§
Superior 120.71 6 17.10 115.09–126.33 120.38 6 16.88 114.49–126.27 0.935§
Nasal 71.61 6 9.65 68.43–74.78 75.38 6 15.09 70.12–80.65 0.217§
Inferior 129.18 6 14.72 124.35–134.02 131.03 6 25.62 122.09–139.97 0.693‡
Temporal 63.42 6 10.44 59.99–66.85 70.29 6 15.09 65.03–75.56 0.033‡
Sleep characteristics
PSG
AHI (events/h) 5.25 6 4.38 2.91–7.59 40.87 6 26.13 33.20–48.54 <0.001‡
ODI (events/h) 5.26 6 7.20 1.42–9.09 19.39 6 16.81 13.87–24.92 <0.001‡
Total sleep time (min) 391.19 6 35.83 372.09–410.28 351.40 6 60.58 333.62–369.19 0.010‡
Total arousal index (events/h) 12.83 6 6.79 9.21–16.44 41.33 6 25.17 33.77–48.90 <0.001‡
SaO2 minimum % 88.25 6 3.33 86.47–90.03 78.30 6 7.52 76.09–80.51 <0.001‡
Wake after sleep onset (min) 57.46 6 22.35 45.55–69.37 95.66 6 49.84 81.03–110.29 0.006‡
REM sleep (%) 21.03 6 3.91 18.94–23.11 17.83 6 15.15 13.38–22.28 0.014‡
PSQI
Sleep efficiency 0.24 6 0.57 0.07–0.41 0.84 6 1.14 0.49–1.19 0.006‡
Sleep latency 1.17 6 0.85 0.92–1.43 1.23 6 1.03 0.91–1.54 0.952‡
Daytime dysfunction 0.63 6 0.74 0.41–0.85 1.39 6 1.06 1.06–1.71 <0.001‡
Sleep duration 0.61 6 0.77 0.38–0.84 1.43 6 8.46 1.17–1.69 <0.001‡
Sleep disturbance 1.43 6 0.58 1.26–1.61 2.11 6 7.84 1.88–2.35 <0.001‡
Sleep medication 0.26 6 0.85 0.01–0.51 0.39 6 0.89 0.11–0.66 0.150‡
Sleep quality 0.89 6 0.71 0.68–1.10 1.93 6 0.82 1.68–2.68 <0.001‡
PSQI global score 5.24 6 3.18 4.29–6.18 9.32 6 4.27 8.02–10.62 <0.001‡
BCVA, best-corrected visual acuity; PSD, pattern standard deviation; VFI, visual field index; REM, rapid eye movement; SaO2, oxyhemoglobin
saturation; SE, spherical equivalent.
* Pearson’s X2 test.
† Brown-Forsythe ANOVA.
‡ Mann-Whitney U test.
§ t-test.
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RESULTS
This study included 47 eyes from 27 patients with OSA aging
from 37 to 72 years (mean 6 SD ¼ 52.60 6 9.13 years, 13
females) and 46 eyes from 25 healthy control participants
aging from 38 to 74 years (54.28 6 8.89 years, 17 females).
Eleven eyes (7 from OSA patients and 4 from controls) were
excluded according to exclusion criteria. OSA severity was
categorized based on the AHI, into moderate (22 eyes) and
severe (25 eyes). For statistical analyses, moderate and severe
OSA patients were combined into a single group. There was no
statistically significant difference between each group in terms
of age, sex, or visual acuity (P > 0.050). Spherical refractive
error and IOP showed a difference between groups (P <
0.010) but all participants met the inclusion criteria (IOP < 21
mm Hg and spherical refraction within 6 5.00 D and cylinder
refraction within 6 3.00 D, to avoid that high refraction errors
to interfere in retinal anatomy and consequently affect the PLR
results). Neither the mean VF test by SAP nor the mean RNFL
thickness measured with OCT for all quadrants differed
significantly between groups (P > 0.050) with exception of
the temporal quadrant (P¼0.033). Table 1 shows relevant data
on demographic, ophthalmologic, and sleep parameters of the
groups.
Rod, Cone, and ipRGC Contributions to the PLR
Table 2 presents the mean PLR measurements for all
participants. Figure 2 presents the normalized mean PLR to
different flash luminances for control and OSA groups. The
normalized peak pupil constriction amplitude of the transient
phase as a function of blue and red flash luminance for the
groups is shown in Figure 3. Comparison between OSA and
control groups for peak pupil constriction amplitude in
response to blue stimuli showed significant differences at 3
log cd/m2 (P¼ 0.013),2 log cd/m2 (P¼ 0.041),1 log cd/m2
(P¼0.008), and 1 log cd/m2 (P¼0.038). Significant differences
were found at all luminance conditions of the red flash (P <
0.050).
Figure 4 shows the PIPR amplitude of the PLR between 6
and 8 seconds after light offset for the blue stimuli. Statistical
comparisons between groups showed no significant differenc-
es in the contributions of ipRGCs to the PLR (P > 0.050).
Figure 5 shows the average of the PL of the PLR to blue and
red stimuli. PL comparisons between OSA and control groups
for the blue and red stimuli showed significant differences (P <
0.050) at 2, 0, 2, 2.4 log cd/m2, and at 2 and 0 log cd/m2,
respectively.
It is worth noting that the above PLR significant differences
are based on the statistical analysis from both eyes for each
participant. However, most of the significant differences
remain with the analysis of one eye for each participant (see
Supplementary Table S2).
Cambridge Colour Test (CCT)
Results of the Trivector and Ellipse protocols (Figs. 6, 7) did
not show significant differences between OSA and control
groups (P > 0.050).
TABLE 2. Mean 6 SD Pupillary Light Measurements in Control and OSA Subjects
Stimuli, log phot cd/m2
Control Subjects (n ¼ 46) OSA Subjects, Moderate to Severe OSA (n ¼ 47)
P Value*Mean 6 SD 95% CI Mean 6 SD 95% CI
Blue
PA 3 0.29 6 0.06 0.27–0.30 0.25 6 0.06 0.23–0.27 0.005
PA 2 0.37 6 0.05 0.35–0.38 0.34 6 0.06 0.32–0.36 0.041
PA 1 0.41 6 0.05 0.39–0.42 0.37 6 0.06 0.35–0.39 0.008
PA 0 0.45 6 0.05 0.43–0.46 0.43 6 0.07 0.41–0.45 0.170
PA 1 0.49 6 0.05 0.47–0.50 0.46 6 0.06 0.44–0.48 0.038
PA 2 0.54 6 0.06 0.52–0.56 0.54 6 0.07 0.52–0.56 0.851
PA 2.4 0.57 6 0.05 0.55–0.58 0.56 6 0.06 0.54–0.58 0.689
PL 3 1.10 6 0.19 1.04–1.15 1.11 6 0.19 1.05–1.16 0.823
PL 2 1.22 6 0.18 1.16–1.28 1.30 6 0.13 1.26–1.34 0.037
PL 1 1.29 6 0.15 1.24–1.33 1.36 6 0.22 1.29–1.42 0.128
PL 0 1.34 6 0.15 1.30–1.39 1.41 6 0.12 1.38–1.45 0.024
PL 1 1.52 6 0.40 1.40–1.64 1.64 6 0.51 1.50–1.79 0.233
PL 2 2.02 6 0.90 1.75–2.29 2.78 6 1.12 2.45–3.11 0.001
PL 2.4 2.16 6 0.94 1.88–2.15 2.78 6 0. 93 2.51–3.10 0.005
PIPR 2 0.40 6 0.10 0.37–0.43 0.43 6 0.11 0.40–0.46 0.115
PIPR 2.4 0.45 6 0.07 0.39–0.44 0.49 6 0.10 0.46–0.52 0.056
Red
PA 2 0.12 6 0.05 0.10–0.14 0.09 6 0.04 0.07–0.10 0.004
PA 1 0.33 6 0.05 0.31–0.34 0.28 6 0.07 0.26–0.30 0.005
PA 0 0.40 6 0.05 0.39–0.42 0.36 6 0.05 0.35–0.38 0.002
PA 1 0.47 6 0.05 0.45–0.48 0.44 6 0.06 0.42–0.45 0.011
PA 2 0.51 6 0.05 0.49–0.53 0.46 6 0.06 0.45–0.48 0.001
PA 2.4 0.52 6 0.05 0.51–0.54 0.50 6 0.04 0.48–0.51 0.042
PL 2 0.83 6 0.16 0.78–0.88 0.72 6 0.26 0.63–0.81 0.032
PL 1 1.13 6 0.18 1.07–1.18 1.16 6 0.17 1.11–1.21 0.479
PL 0 1.24 6 0.15 1.19–1.28 1.31 6 0.12 1.28–1.35 0.026
PL 1 1.36 6 0.08 1.34–1.39 1.38 6 0.10 1.35–1.41 0.435
PL 2 1.37 6 0.09 1.34–1.39 1.40 6 0.12 1.37–1.44 0.129
PL 2.4 1.40 6 0.17 1.35–1.45 1.39 6 0.17 1.34–1.44 0.776
* Generalized estimating equation.
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Sleep Parameters
OSA patients had significant differences in the PSG parameters
and higher PSQI components (P < 0.015) than controls as it is
expected in OSA, except for sleep latency and sleep
medication questions of the PSQI (P > 0.150; Table 1).
Relations Between PLR and Clinical Measures in
OSA
Analysis of the transient PLR amplitude indicated significant
correlations among some visual functions, retinal, morphologic
parameters, and sleep parameters. There was a negative
correlation between ODI and the PLR peak pupil constriction
amplitude for the blue flash luminance at 1 log cd/m2 (R ¼
0.516 R2 ¼ 0.266; P ¼ 0.003; Supplementary Fig. S1). A
significant positive correlation was observed between the
mean OCT T with ODI (R ¼ 0.516 R2 ¼ 0.266; P ¼ 0.008;
Supplementary Fig. S2). There was a positive correlation
between the PLR peak pupil constriction amplitude for the
blue flash luminance at 2 log cd/m2 and the total sleep time
(TST; R¼ 0.490 R2¼ 0.240; P¼ 0.003; Supplementary Fig. S3).
DISCUSSION
To our knowledge, this is the first study to investigate the OSA
impact on the rod/cone and ipRGC contributions to PLR. We
assessed the PLR under conditions designed to preferentially
elicit the contribution of the inner and outer retinal
photoreceptors and we endeavored to ensure that our study
included only patients diagnosed with OSA without co-
morbidities that might have affected the visual system. Our
data showed at low luminance levels (3, 2, and 1 log cd/
m2) for the blue flash and at all luminance levels for the red
flash the OSA group had a significantly lower peak pupil
constriction amplitude relative to the control group. Therefore,
at low luminance levels, the contributions of the rods to the
PLR were significantly lower in comparison to the control
group. A decrease of the peak pupil constriction amplitude
responses for long-wavelength stimuli at high-luminance points
out to a reduced rod/cone contribution in moderate and severe
OSA patients. Additionally, the OSA group exhibited longer
constriction latency. It has been previously shown that pupil
latency can be delayed in some diseases due to an afferent-
based pathway dysfunction.63,64
FIGURE 2. Normalized pupillary diameter for different flash luminance levels. PLR to blue flashes are shown in the upper panels as the average of
results from controls and patients with OSA. PLR results to red flashes are shown in the lower panels as the average of the two groups. Red and blue
bars represent the 1-second stimulus flashes.
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In the avascular outer retina, rod photoreceptors are among
the most metabolically active cells of the central nervous
system and during darkness, the metabolic process requires
the highest oxygen consumption of any tissue of the body.65
The oxygen consumption of rods and cones increases as light
levels fall.65,66 OSA-induced hypoxia leads to inflammatory
responses, vascular dysregulation, endothelial dysfunction, and
oxidative damage, and it is thought to be one of the most
critical pathogenesis factors for ischemic retinal diseases, such
as proliferative diabetic retinopathy, retinal vessel occlusion,
and oxygen-induced retinopathy.5,6,15 Here, correlations be-
tween the PLR and sleep parameters indicated that a reduced
peak pupil response to blue flash luminance at 2 and 1 log
cd/m2 (rod condition) was associated with reduced TST and
increased levels of the ODI, respectively. Thus, dysfunctional
contributions of the outer retina to PLR found in this study may
be associated with OSA’s chronic and intermittent hypoxia.
Even though the RGCs are sensitive to hypoxic conditions,
which may cause damage or loss of these cells, the ipRGCs
seem to have an injury-resistant character compared with other
retinal cells.67–71 Our findings agree with this observation as
the ipRGC contributions to the PLR assessed by the amplitude
of the PIPR between 6 and 8 seconds were preserved in OSA
patients.
The ipRGC cells, especially the M1 ipRGC subtype, send
their axons to the suprachiasmatic nucleus (SCN) of the
hypothalamus to mediate circadian regulation and to other
brain nuclei, including the olivary pretectal nucleus involved in
the PLR.72,73 Melatonin secretion is driven by the master
circadian clock SCN and it has been considered a stable
biomarker, the gold standard of circadian phase entrain-
ment.74,75 Some studies have reported that in OSA patients
there is an alteration in circadian rhythms and melatonin
FIGURE 3. Pupil constriction amplitude as a function of flash
luminance, for red and blue stimuli. OSA patients are represented by
dashed lines. Controls are represented by solid lines. The vertical bars
represent the standard error of the mean for each group. Significant
comparisons are marked with * where P < 0.050. For the blue
luminance significant differences were found between OSA and control
groups at 3, 1, 0, and 1 log phot cd/m2. For the red luminance
significant differences were found for all tested luminances.
FIGURE 4. The normalized constriction amplitude of the pupillary
sustained response (or PIPR) measured between 6 and 8 seconds after
blue flash offset for the control and OSA groups. Vertical bars
represent the standard error of the mean.
FIGURE 5. Pupil constriction latency as a function of flash luminance
for red and blue stimuli. Dashed lines represent OSA patients. Solid
lines represent controls. The vertical bars represent the standard error
of the mean for each group. Significant comparisons are marked with *
for the blue luminance and . for the red luminance where P < 0.050.
FIGURE 6. Color discrimination thresholds (in u’v’ units 3 104) for
protan, deutan, and tritan confusion axes measured with the CCT. The
vertical bars represent the standard error of the mean for each group.
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secretion,22–24,76 but our results did not find reduced
melanopsin-driven responses in OSA patients. Moreover, in
this study, the OSA group presented an enhanced but not
statistically significant ipRGC response to PLR compared with
controls (Fig. 4).
Le´on et al.77 have reported a delayed pupillary re-dilation
response after a bright blue light offset significantly greater in
patients with outer retinal disease compared with controls.
They proposed that the loss of rod and cone contributions to
the PLR might be pathologically altered in favor of the
melanopsin pupillary response. Further, a previous work of
Hannibal et al.78 reported a higher density in the temporal
retina of M1 ipRGC cells, which project mainly to the olivary
pretectal nucleus and SCN. Therefore, the enhanced PIPR of
the OSA group may be associated to reduced outer retinal
photoreceptor contributions to PLR in favor of melanopsin
and/or to the only significant difference found in the temporal
quadrant of the RNFL thickness, but it is important to note that
the mean RNFL thickness values for both groups were within
the normal range.79
Previous papers have reported a strong link between OSA
and optic nerve disorders.7,19–21,80–84 Studies of electrophysi-
ology and RNFL thickness have reported conflicting findings in
OSA patients, some showed significant reduction of the RNFL
thickness,9,19,21,71 pattern electroretinogram (PERG),82,84 and
visual evoked potential (VEP),83,84 while others found no
decrease85–87 or alterations of ERG.83 Our results did not show
any reduction of RNFL thickness or VF in the OSA group, in
agreement with previous studies by Salzgeber et al.,87
Ferrandez et al.,85,86 and Yu et al.,88 which did not find
significant thinning of the RGC layer or macular thickness in
OSA patients. Various authors have found affected values of
MD and PSD in OSA patients,89–91 and Ferrandez et al.85 have
reported an impairment in the VF evaluated by SAP, suggesting
dysfunction but not the death of the RGC. Findings by Yu et
al.88 suggest that the vascular changes might occur before
changes in RNFL thickness and vascular impairment of the
vessel densities, which are more prominent in the peripapillary
area in moderate OSA.
The fact that several studies found no differences in the
ophthalmologic variables measured in OSA patients compared
with controls, may be due to the possibility that OSA duration,
rather than its severity, could be a more determining factor in
the association with retinal diseases.20,92,93 In this study, the
onset of the disease remains uncertain because it was based on
the patients’ reports, which in most cases did not exceed 4
years. Therefore, OSA patients were evaluated in a baseline
condition. These facts show a limitation in the design of this
cross-sectional study; longitudinal studies with larger cohorts
are needed to assess the progressive effect of OSA on the
photoreceptors and its relation to a short- or long-term
treatment.
In summary, this is a pioneer study that evaluated the
impact of OSA on photoreceptor contributions to PLR. As
noted above, we did not find color vision defects, reduction of
RNFL thickness or VF in OSA patients, but we found significant
differences only through the pupillometry protocol. The
contributions of the outer retina photoreceptors, rod and
cones, to the PLR were affected in moderate and severe OSA
patients. In contrast, the contribution of the inner retina
photoreceptors to the PLR was preserved. In this context,
results indicate that pupillometry can be used as a sensitive
noninvasive and promising method for early detection of
retinal dysfunction even before major symptoms or ocular
diseases appears.
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